rs17078720

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_014363.6(SACS):​c.-13A>G variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.321 in 1,595,820 control chromosomes in the GnomAD database, including 85,085 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.29 ( 6804 hom., cov: 33)
Exomes 𝑓: 0.32 ( 78281 hom. )

Consequence

SACS
NM_014363.6 5_prime_UTR

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 0.418

Publications

14 publications found
Variant links:
Genes affected
SACS (HGNC:10519): (sacsin molecular chaperone) This gene encodes the sacsin protein, which includes a UbL domain at the N-terminus, a DnaJ domain, and a HEPN domain at the C-terminus. The gene is highly expressed in the central nervous system, also found in skin, skeletal muscles and at low levels in the pancreas. This gene includes a very large exon spanning more than 12.8 kb. Mutations in this gene result in autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS), a neurodegenerative disorder characterized by early-onset cerebellar ataxia with spasticity and peripheral neuropathy. The authors of a publication on the effects of siRNA-mediated sacsin knockdown concluded that sacsin protects against mutant ataxin-1 and suggest that "the large multi-domain sacsin protein is able to recruit Hsp70 chaperone action and has the potential to regulate the effects of other ataxia proteins" (Parfitt et al., PubMed: 19208651). A pseudogene associated with this gene is located on chromosome 11. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013]
SACS Gene-Disease associations (from GenCC):
  • Charlevoix-Saguenay spastic ataxia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, PanelApp Australia, G2P, Myriad Women’s Health, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 13-23411252-T-C is Benign according to our data. Variant chr13-23411252-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 260389.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.452 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_014363.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SACS
NM_014363.6
MANE Select
c.-13A>G
5_prime_UTR
Exon 2 of 10NP_055178.3
SACS
NM_001437336.1
c.-13A>G
5_prime_UTR
Exon 2 of 11NP_001424265.1A0A804HIQ1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SACS
ENST00000382292.9
TSL:5 MANE Select
c.-13A>G
5_prime_UTR
Exon 2 of 10ENSP00000371729.3Q9NZJ4-1
SACS
ENST00000455470.6
TSL:1
c.-13A>G
5_prime_UTR
Exon 2 of 11ENSP00000406565.2H0Y6M8
SACS
ENST00000682547.1
c.25A>Gp.Arg9Gly
missense
Exon 2 of 4ENSP00000507735.1A0A804HK18

Frequencies

GnomAD3 genomes
AF:
0.286
AC:
43515
AN:
151930
Hom.:
6799
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.157
Gnomad AMI
AF:
0.336
Gnomad AMR
AF:
0.286
Gnomad ASJ
AF:
0.448
Gnomad EAS
AF:
0.467
Gnomad SAS
AF:
0.388
Gnomad FIN
AF:
0.351
Gnomad MID
AF:
0.370
Gnomad NFE
AF:
0.324
Gnomad OTH
AF:
0.310
GnomAD2 exomes
AF:
0.327
AC:
81255
AN:
248422
AF XY:
0.335
show subpopulations
Gnomad AFR exome
AF:
0.155
Gnomad AMR exome
AF:
0.239
Gnomad ASJ exome
AF:
0.443
Gnomad EAS exome
AF:
0.477
Gnomad FIN exome
AF:
0.349
Gnomad NFE exome
AF:
0.322
Gnomad OTH exome
AF:
0.321
GnomAD4 exome
AF:
0.324
AC:
468199
AN:
1443772
Hom.:
78281
Cov.:
29
AF XY:
0.327
AC XY:
235194
AN XY:
719386
show subpopulations
African (AFR)
AF:
0.152
AC:
5062
AN:
33232
American (AMR)
AF:
0.246
AC:
10992
AN:
44668
Ashkenazi Jewish (ASJ)
AF:
0.444
AC:
11531
AN:
25998
East Asian (EAS)
AF:
0.435
AC:
17223
AN:
39568
South Asian (SAS)
AF:
0.386
AC:
33121
AN:
85754
European-Finnish (FIN)
AF:
0.342
AC:
18221
AN:
53352
Middle Eastern (MID)
AF:
0.358
AC:
2054
AN:
5742
European-Non Finnish (NFE)
AF:
0.319
AC:
350015
AN:
1095692
Other (OTH)
AF:
0.334
AC:
19980
AN:
59766
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.453
Heterozygous variant carriers
0
13914
27828
41742
55656
69570
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
11392
22784
34176
45568
56960
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.286
AC:
43543
AN:
152048
Hom.:
6804
Cov.:
33
AF XY:
0.294
AC XY:
21837
AN XY:
74320
show subpopulations
African (AFR)
AF:
0.157
AC:
6515
AN:
41510
American (AMR)
AF:
0.286
AC:
4376
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.448
AC:
1553
AN:
3466
East Asian (EAS)
AF:
0.467
AC:
2416
AN:
5170
South Asian (SAS)
AF:
0.388
AC:
1869
AN:
4822
European-Finnish (FIN)
AF:
0.351
AC:
3703
AN:
10542
Middle Eastern (MID)
AF:
0.381
AC:
112
AN:
294
European-Non Finnish (NFE)
AF:
0.324
AC:
22041
AN:
67946
Other (OTH)
AF:
0.309
AC:
652
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1530
3060
4591
6121
7651
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
444
888
1332
1776
2220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.278
Hom.:
2784
Bravo
AF:
0.274
Asia WGS
AF:
0.400
AC:
1392
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not specified (4)
-
-
2
Charlevoix-Saguenay spastic ataxia (2)
-
-
2
not provided (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
6.9
DANN
Benign
0.74
PhyloP100
0.42
Mutation Taster
=300/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17078720; hg19: chr13-23985391; COSMIC: COSV66534551; API